{"entity":{"type":"insider","cik":"0001378585","url":"/insider/0001378585","json_url":"/insider/0001378585.json","name":"Scheer David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2010-04-15","last":"2019-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Scheer David","source":"filing","n_filings":4,"first_seen":"2010-04-15","last_seen":"2019-11-14"}],"transactions":[{"id":8719890,"accession":"0001562180-19-005523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-19-005523","line_url":"/filing/0001562180-19-005523#line-2","is_derivative":false,"issuer_cik":"0001070336","issuer_name":"ACHILLION PHARMACEUTICALS INC","issuer_ticker":"ACHN","issuer_name_source":null,"issuer_url":"/issuer/0001070336","owner_cik":"0001378585","owner_name":"Scheer David","owner_url":"/insider/0001378585","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10485.0,"shares_display":"10,485","price_per_share":6.3135,"price_display":"6.31","price_state":"stated","total_value":66197.0475,"total_display":"66,197.05","shares_owned_after":29515.0,"shares_owned_after_display":"29,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-13","filed_date":"2019-11-14","scope":"insider"},{"id":5391360,"accession":"0001181431-13-046220","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-046220","line_url":"/filing/0001181431-13-046220#line-2","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001378585","owner_name":"Scheer David","owner_url":"/insider/0001378585","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19600.0,"shares_display":"19,600","price_per_share":84.572,"price_display":"84.57","price_state":"stated","total_value":1657611.2,"total_display":"1,657,611.20","shares_owned_after":620554.0,"shares_owned_after_display":"620,554","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-21","filed_date":"2013-08-23","scope":"insider"},{"id":5391357,"accession":"0001181431-13-046220","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-046220","line_url":"/filing/0001181431-13-046220#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001378585","owner_name":"Scheer David","owner_url":"/insider/0001378585","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":85.068,"price_display":"85.07","price_state":"stated","total_value":34027.2,"total_display":"34,027.20","shares_owned_after":620154.0,"shares_owned_after_display":"620,154","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-08-21","filed_date":"2013-08-23","scope":"insider"},{"id":8924398,"accession":"0001181431-11-017661","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-017661","line_url":"/filing/0001181431-11-017661#line-2","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001378585","owner_name":"Scheer David","owner_url":"/insider/0001378585","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6006.0,"shares_display":"6,006","price_per_share":15.36,"price_display":"15.36","price_state":"stated","total_value":92252.16,"total_display":"92,252.16","shares_owned_after":650154.0,"shares_owned_after_display":"650,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-11","filed_date":"2011-03-14","scope":"insider"},{"id":8924396,"accession":"0001181431-11-017661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-017661","line_url":"/filing/0001181431-11-017661#line-1","is_derivative":false,"issuer_cik":"0001338042","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001338042","owner_cik":"0001378585","owner_name":"Scheer David","owner_url":"/insider/0001378585","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3994.0,"shares_display":"3,994","price_per_share":15.11,"price_display":"15.11","price_state":"stated","total_value":60349.34,"total_display":"60,349.34","shares_owned_after":644148.0,"shares_owned_after_display":"644,148","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-10","filed_date":"2011-03-14","scope":"insider"},{"id":7158600,"accession":"0001181431-10-021707","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-021707","line_url":"/filing/0001181431-10-021707#line-2","is_derivative":false,"issuer_cik":"0001296391","issuer_name":"TENGION INC","issuer_ticker":"TNGN","issuer_name_source":null,"issuer_url":"/issuer/0001296391","owner_cik":"0001378585","owner_name":"Scheer David","owner_url":"/insider/0001378585","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","shares_owned_after":175495.0,"shares_owned_after_display":"175,495","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-04-14","filed_date":"2010-04-15","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070336","name":"ACHILLION PHARMACEUTICALS INC","url":"/issuer/0001070336","role":"Director","n_filings":1,"first_seen":"2019-11-14","last_seen":"2019-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Director","n_filings":2,"first_seen":"2011-03-14","last_seen":"2013-08-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001296391","name":"TENGION INC","url":"/issuer/0001296391","role":"Director","n_filings":1,"first_seen":"2010-04-15","last_seen":"2010-04-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001378585","retrieved_at":"2026-08-21T12:06:26+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}